Batch:
All in vitro solubility values are batch-tested experimental data (non-literature values).
| Solvent | Solubility & Note |
|---|---|
| DMSO |
85 mg/mL
(198.46 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 1 mg/mL |
| Water | Insoluble |
| DMSO |
86 mg/mL
(200.79 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
| DMSO |
29 mg/mL
(67.71 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
| DMSO |
22 mg/mL
(51.36 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
| DMSO |
86 mg/mL
(200.79 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | ˂1 mg/mL |
| Ethanol | ˂1 mg/mL |
Q: Why does a DMSO stock precipitate in media/saline?
A: It is caused by unheated aqueous media (supersaturation), local solvent shock, or incorrect mixing sequence.
How to fix it?
- Preheat media/saline to 37°C.
- Mix rapidly (pipette/vortex) upon addition.
- For complex mixes, always add the aqueous phase last.
- Re-dissolve minor precipitates with a 37°C water bath and sonication (≤30 min).
Check the
Eltanexor (KPT-8602)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
|
Concentration
Volume
Mass
|
|---|
Pre-aliquoted for Longevity: Solid-state aliquots offer significantly longer shelf life compared to stock solutions, ensuring maximum stability for every use.
Looking for a specific aliquot size? Reach out to your local sales representative or contact us at orders@selleckchem.com.
Batch:
| Administration Route | Formulation Type | Formulation Details | Solubility | Preparation Method |
|---|
Other Animals:
- Eltanexor (KPT-8602) Mechanism of Action: XPO1 Inhibition in Hematopoietic Malignant Cell Research
- Eltanexor (KPT-8602) Clinical Trials
- Eltanexor (KPT-8602) Working Concentration | Cell Culture | Treatment
- Eltanexor (KPT-8602) Stock Solution
- Eltanexor (KPT-8602) Storage
- Eltanexor (KPT-8602) Stability
- Eltanexor (KPT-8602) Combination Database
- Eltanexor (KPT-8602) Molecular Weight
- Eltanexor (KPT-8602) SMILES
- Eltanexor (KPT-8602) CAS Number
- Eltanexor (KPT-8602) Chemical Structure (2D and 3D)
- Eltanexor (KPT-8602) IC50 for Cell-based and Cell-free Assays
- Eltanexor (KPT-8602) Sigma (BL3H9998F935)? Try a better option.
- Eltanexor (KPT-8602) APExBIO (B8335)? Try a better option.
- Eltanexor (KPT-8602) Cayman (43585)? Try a better option.
- Eltanexor (KPT-8602) MedChemExpress (HY-100423)? Try a better option.
- Eltanexor (KPT-8602) SDS|MSDS
Note: Technical data last updated: Sep 1, 2026.